Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

Abstract Background Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk f...

Descripción completa

Detalles Bibliográficos

Autores principales:	Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish, the COVID‐19 Consortium Group
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2021-02-01
Colección:	Research and Practice in Thrombosis and Haemostasis
Materias:	COVID‐19 hospitalized patients risk assessment thromboembolism thrombosis
Acceso en línea:	https://doi.org/10.1002/rth2.12486
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!